EXAS vs VEEV · rev $2.76B vs P/E 27, rev $1.81B
EXACT Sciences Corporation (EXAS) versus Veeva Systems Inc Class A (VEEV) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Veeva Systems Inc Class A (VEEV) is a health information services company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported VEEV revenue for 2026-07-31 was $1.81B. Net income was $534.4M. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
EXAS currently screens at market cap $20.03B. VEEV currently screens at market cap $25.15B and trailing P/E 27.5.
Not investment advice. Open the EXAS and VEEV stock pages for the full models.
Not investment advice.